vs
Side-by-side financial comparison of Presurance Holdings, Inc. (PRHI) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $5.7M, roughly 1.1× Presurance Holdings, Inc.). Prelude Therapeutics Inc runs the higher net margin — -303.5% vs -369.2%, a 65.7% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs -61.4%).
PRHI vs PRLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.7M | $6.5M |
| Net Profit | $-17.0M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | -322.7% | -314.1% |
| Net Margin | -369.2% | -303.5% |
| Revenue YoY | -61.4% | 116.7% |
| Net Profit YoY | 32.9% | 38.9% |
| EPS (diluted) | $-1.40 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.7M | — | ||
| Q3 25 | $6.8M | $6.5M | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.9M | — | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $16.0M | $3.0M | ||
| Q2 24 | $17.9M | — | ||
| Q1 24 | $18.6M | — |
| Q4 25 | $-17.0M | — | ||
| Q3 25 | $-4.0M | $-19.7M | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $522.0K | — | ||
| Q4 24 | $-25.4M | — | ||
| Q3 24 | $52.8M | $-32.3M | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $74.0K | — |
| Q4 25 | -322.7% | — | ||
| Q3 25 | -42.7% | -314.1% | ||
| Q2 25 | -22.6% | — | ||
| Q1 25 | -27.9% | — | ||
| Q4 24 | -177.1% | — | ||
| Q3 24 | -45.8% | -1145.9% | ||
| Q2 24 | -24.3% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | -369.2% | — | ||
| Q3 25 | -58.2% | -303.5% | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | -172.4% | — | ||
| Q3 24 | 329.6% | -1075.7% | ||
| Q2 24 | -22.1% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | $-1.40 | — | ||
| Q3 25 | $-0.32 | $-0.26 | ||
| Q2 25 | $0.17 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $-2.08 | — | ||
| Q3 24 | $4.32 | $-0.43 | ||
| Q2 24 | $-0.32 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.1M | $55.0M |
| Total DebtLower is stronger | $12.2M | — |
| Stockholders' EquityBook value | $9.0M | $58.5M |
| Total Assets | $239.3M | $94.8M |
| Debt / EquityLower = less leverage | 1.36× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.1M | — | ||
| Q3 25 | $62.3M | $55.0M | ||
| Q2 25 | $58.3M | — | ||
| Q1 25 | $52.3M | — | ||
| Q4 24 | $48.8M | — | ||
| Q3 24 | $53.6M | $153.6M | ||
| Q2 24 | $33.0M | — | ||
| Q1 24 | $41.0M | — |
| Q4 25 | $12.2M | — | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $12.1M | — | ||
| Q1 25 | $12.0M | — | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $16.5M | — | ||
| Q2 24 | $24.8M | — | ||
| Q1 24 | $24.9M | — |
| Q4 25 | $9.0M | — | ||
| Q3 25 | $25.3M | $58.5M | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $25.6M | — | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $49.1M | $156.4M | ||
| Q2 24 | $-1.2M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $239.3M | — | ||
| Q3 25 | $285.0M | $94.8M | ||
| Q2 25 | $283.3M | — | ||
| Q1 25 | $277.1M | — | ||
| Q4 24 | $281.7M | — | ||
| Q3 24 | $299.9M | $197.2M | ||
| Q2 24 | $292.9M | — | ||
| Q1 24 | $301.1M | — |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.55× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 9.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-43.9M | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-43.9M | — | ||
| Q3 25 | $-681.0K | $-19.1M | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $-15.3M | — | ||
| Q4 24 | $-32.7M | — | ||
| Q3 24 | $-10.7M | $-27.3M | ||
| Q2 24 | $-10.1M | — | ||
| Q1 24 | $8.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.34× | — | ||
| Q1 25 | -29.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.20× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 110.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
